Cargando…
Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction
Cancer stem cells (CSCs) have high tumor-initiating capacity and are resistant to chemotherapeutic reagents; thus eliminating CSCs is essential to improving the prognosis. Recently, we reported that dexamethasone increases the effects of gemcitabine on pancreatic CSCs; however, the mechanism involve...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470402/ https://www.ncbi.nlm.nih.gov/pubmed/34575034 http://dx.doi.org/10.3390/life11090885 |
_version_ | 1784574190059257856 |
---|---|
author | Suzuki, Shuhei Yamamoto, Masahiro Sanomachi, Tomomi Togashi, Keita Sugai, Asuka Seino, Shizuka Yoshioka, Takashi Okada, Masashi Kitanaka, Chifumi |
author_facet | Suzuki, Shuhei Yamamoto, Masahiro Sanomachi, Tomomi Togashi, Keita Sugai, Asuka Seino, Shizuka Yoshioka, Takashi Okada, Masashi Kitanaka, Chifumi |
author_sort | Suzuki, Shuhei |
collection | PubMed |
description | Cancer stem cells (CSCs) have high tumor-initiating capacity and are resistant to chemotherapeutic reagents; thus eliminating CSCs is essential to improving the prognosis. Recently, we reported that dexamethasone increases the effects of gemcitabine on pancreatic CSCs; however, the mechanism involved remains to be fully elucidated. In this study, we explored the role of reactive oxygen species (ROS) in the dexamethasone-induced chemosensitization of CSCs. Dexamethasone increased the growth-inhibitory effects of gemcitabine and 5-fluorouracil, whereas N-acetyl-cysteine, a ROS scavenger, abolished this effect. Although dexamethasone alone did not increase ROS levels, dexamethasone promoted the increase in ROS levels induced by gemcitabine and 5-fluorouracil. Dexamethasone treatment reduced the expression of NRF2, a key regulator of antioxidant responses, which was attenuated by siRNA-mediated knockdown of the glucocorticoid receptor. Furthermore, brusatol, a suppressor of NRF2, sensitized pancreatic CSCs to gemcitabine and 5-fluorouracil. Of note, essentially, the same mechanism was functional in ovarian and colon CSCs treated by the combination of dexamethasone and chemotherapeutic agents. Our study suggests that dexamethasone can sensitize CSCs to chemotherapeutic agents by promoting chemotherapy-induced ROS production through suppressing NRF2 expression. |
format | Online Article Text |
id | pubmed-8470402 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84704022021-09-27 Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction Suzuki, Shuhei Yamamoto, Masahiro Sanomachi, Tomomi Togashi, Keita Sugai, Asuka Seino, Shizuka Yoshioka, Takashi Okada, Masashi Kitanaka, Chifumi Life (Basel) Article Cancer stem cells (CSCs) have high tumor-initiating capacity and are resistant to chemotherapeutic reagents; thus eliminating CSCs is essential to improving the prognosis. Recently, we reported that dexamethasone increases the effects of gemcitabine on pancreatic CSCs; however, the mechanism involved remains to be fully elucidated. In this study, we explored the role of reactive oxygen species (ROS) in the dexamethasone-induced chemosensitization of CSCs. Dexamethasone increased the growth-inhibitory effects of gemcitabine and 5-fluorouracil, whereas N-acetyl-cysteine, a ROS scavenger, abolished this effect. Although dexamethasone alone did not increase ROS levels, dexamethasone promoted the increase in ROS levels induced by gemcitabine and 5-fluorouracil. Dexamethasone treatment reduced the expression of NRF2, a key regulator of antioxidant responses, which was attenuated by siRNA-mediated knockdown of the glucocorticoid receptor. Furthermore, brusatol, a suppressor of NRF2, sensitized pancreatic CSCs to gemcitabine and 5-fluorouracil. Of note, essentially, the same mechanism was functional in ovarian and colon CSCs treated by the combination of dexamethasone and chemotherapeutic agents. Our study suggests that dexamethasone can sensitize CSCs to chemotherapeutic agents by promoting chemotherapy-induced ROS production through suppressing NRF2 expression. MDPI 2021-08-27 /pmc/articles/PMC8470402/ /pubmed/34575034 http://dx.doi.org/10.3390/life11090885 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Suzuki, Shuhei Yamamoto, Masahiro Sanomachi, Tomomi Togashi, Keita Sugai, Asuka Seino, Shizuka Yoshioka, Takashi Okada, Masashi Kitanaka, Chifumi Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction |
title | Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction |
title_full | Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction |
title_fullStr | Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction |
title_full_unstemmed | Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction |
title_short | Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction |
title_sort | dexamethasone sensitizes cancer stem cells to gemcitabine and 5-fluorouracil by increasing reactive oxygen species production through nrf2 reduction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470402/ https://www.ncbi.nlm.nih.gov/pubmed/34575034 http://dx.doi.org/10.3390/life11090885 |
work_keys_str_mv | AT suzukishuhei dexamethasonesensitizescancerstemcellstogemcitabineand5fluorouracilbyincreasingreactiveoxygenspeciesproductionthroughnrf2reduction AT yamamotomasahiro dexamethasonesensitizescancerstemcellstogemcitabineand5fluorouracilbyincreasingreactiveoxygenspeciesproductionthroughnrf2reduction AT sanomachitomomi dexamethasonesensitizescancerstemcellstogemcitabineand5fluorouracilbyincreasingreactiveoxygenspeciesproductionthroughnrf2reduction AT togashikeita dexamethasonesensitizescancerstemcellstogemcitabineand5fluorouracilbyincreasingreactiveoxygenspeciesproductionthroughnrf2reduction AT sugaiasuka dexamethasonesensitizescancerstemcellstogemcitabineand5fluorouracilbyincreasingreactiveoxygenspeciesproductionthroughnrf2reduction AT seinoshizuka dexamethasonesensitizescancerstemcellstogemcitabineand5fluorouracilbyincreasingreactiveoxygenspeciesproductionthroughnrf2reduction AT yoshiokatakashi dexamethasonesensitizescancerstemcellstogemcitabineand5fluorouracilbyincreasingreactiveoxygenspeciesproductionthroughnrf2reduction AT okadamasashi dexamethasonesensitizescancerstemcellstogemcitabineand5fluorouracilbyincreasingreactiveoxygenspeciesproductionthroughnrf2reduction AT kitanakachifumi dexamethasonesensitizescancerstemcellstogemcitabineand5fluorouracilbyincreasingreactiveoxygenspeciesproductionthroughnrf2reduction |